Market
What will be the response of major pharmaceutical companies to the Florida grand jury report by mid-2025?
2
Resolution / Starting Odds
Acknowledgement • 25%
Denial • 25%
No comment • 25%
Legal action • 25%
Official statements or press releases from major pharmaceutical companies
Story
Florida Grand Jury, at DeSantis's Request, Finds No Criminal Activity in COVID-19 Vaccine Probe, Recommends Policy Changes
Jan 7, 2025, 10:30 PM
A statewide grand jury in Florida, convened at the request of Governor Ron DeSantis, has concluded its investigation into the development and safety of COVID-19 vaccines, finding no evidence of criminal activity. The grand jury's final report, released on Tuesday, highlighted 'profound and serious issues' related to the transparency and process of vaccine development and safety surveillance in the United States. Despite not finding any illegal actions, the jury recommended policy changes, including increased transparency around clinical trials and a ban on advertisements for pharmaceutical drugs. The investigation was initiated in 2022 amidst DeSantis's campaign for the Republican presidential nomination, where he positioned himself against pandemic lockdowns and mask mandates. The report also noted that 'Big Pharma' engaged in a 'pattern of deceptive and obfuscatory behavior,' allegedly hiding adverse effects of the vaccines to rake in billions in profit.
View original story
Similar markets
Deny allegations and defend actions • 25%
Other • 25%
No official response • 25%
Acknowledge issues and propose changes • 25%
Support the proposal • 25%
Other response • 25%
Remain neutral • 25%
Oppose the proposal • 25%
Investigation not concluded • 25%
Significant negative impact • 25%
No significant impact • 25%
Positive impact • 25%
Some issue statements • 25%
All issue statements • 25%
Issue joint statement • 25%
None issue statements • 25%
No legislative action • 25%
Investigations into pharmaceutical companies • 25%
New regulations on vaccine transparency • 25%
Other • 25%
No significant change • 25%
Increased trust in vaccines • 25%
Decreased trust in vaccines • 25%
Other • 25%
Reach new settlements with other firms • 25%
Rebrand or restructure • 25%
No significant actions • 25%
File for bankruptcy again • 25%
Compliance • 25%
Other • 25%
Legal challenge • 25%
Product reformulation • 25%
Launch public awareness campaigns • 25%
Other actions • 25%
No significant change • 25%
Implement cancer warnings • 25%
Yes • 50%
No • 50%
No significant reaction • 25%
Increased security measures • 25%
Policy changes or reforms • 25%
Public condemnation only • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Moderna • 25%